Trademark: 86211937
Status Date
Monday, September 7, 2015
Filing Date
Wednesday, March 5, 2014
Published for Opposition
Tuesday, August 5, 2014
Abandoned Date
Monday, September 7, 2015
1 Active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammation; Excipients for use in the manufacture of pharmaceuticals; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Preservatives for pharmaceutical preparations; the foregoing goods containing N-acetylcysteine
5 Anti-diabetic pharmaceuticals; Capsules sold empty for pharmaceuticals; Cardiovascular pharmaceuticals; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a coating for sustained release formulations that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention of inflammation, cardiovascular disease (CVD), multiple sclerosis (MS), and pulmonary diseases, including chronic obstructive pulmonary disease (COPD); Pharmaceutical preparations for the treatment and prevention of diabetes, renal disease, colitis; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, antidepressants; the foregoing goods containing N-acetylcysteine
Color is not claimed as a feature of the mark.
SURE NAC
Sep 8, 2015
Abandonment Notice Mailed - No Use Statement Filed
Sep 7, 2015
Abandonment - No Use Statement Filed
Feb 3, 2015
Noa E-Mailed - Sou Required From Applicant
Dec 19, 2014
Extension Of Time To Oppose Process - Terminated
Aug 21, 2014
Extension Of Time To Oppose Received
Aug 5, 2014
Official Gazette Publication Confirmation E-Mailed
Aug 5, 2014
Published For Opposition
Jul 16, 2014
Notification Of Notice Of Publication E-Mailed
Jul 1, 2014
Law Office Publication Review Completed
Jun 30, 2014
Assigned To Lie
Jun 12, 2014
Approved For Pub - Principal Register
Jun 12, 2014
Examiner's Amendment Entered
Jun 12, 2014
Notification Of Examiners Amendment E-Mailed
Jun 12, 2014
Examiners Amendment E-Mailed
Jun 12, 2014
Examiners Amendment -Written
Jun 10, 2014
Assigned To Examiner
Mar 19, 2014
Notice Of Pseudo Mark E-Mailed
Mar 18, 2014
New Application Office Supplied Data Entered In Tram
Mar 8, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
